HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadafumi Kato Selected Research

Sleepiness

8/2021Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadafumi Kato Research Topics

Disease

93Bipolar Disorder (Manic Depressive Psychosis)
02/2024 - 03/2000
45Schizophrenia (Dementia Praecox)
03/2024 - 02/2003
23Mental Disorders (Mental Disorder)
12/2023 - 08/2003
15Mood Disorders (Mood Disorder)
10/2023 - 12/2006
9Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 10/2004
7Psychotic Disorders (Schizoaffective Disorder)
12/2023 - 08/2005
5Major Depressive Disorder (Major Depressive Disorders)
12/2021 - 12/2012
4Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
06/2005 - 11/2002
3Alzheimer Disease (Alzheimer's Disease)
03/2024 - 08/2006
3Mania (Manias)
12/2023 - 01/2021
3Psychomotor Agitation (Akathisia)
01/2023 - 12/2020
3Inflammation (Inflammations)
01/2022 - 01/2018
3Anxiety Disorders (Anxiety Disorder)
12/2020 - 11/2002
3Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
10/2018 - 04/2005
3Parkinson Disease (Parkinson's Disease)
01/2018 - 08/2006
2Neurodevelopmental Disorders
03/2024 - 05/2023
2Alcoholism (Alcohol Abuse)
12/2023 - 08/2004
2Genetic Risk Score
07/2022 - 11/2021
2Nausea
08/2021 - 12/2020
2Neuroblastoma
01/2015 - 11/2013
2Neoplasms (Cancer)
02/2008 - 08/2006
2Medically Unexplained Symptoms
02/2007 - 12/2004
2MELAS Syndrome (Syndrome, MELAS)
08/2005 - 03/2005
2Poisoning
06/2005 - 11/2002
2Hyperventilation
10/2004 - 01/2003
1Kleefstra Syndrome
03/2024
1Autism Spectrum Disorder
03/2024
1Cognitive Dysfunction
03/2024
1Autistic Disorder (Autism)
03/2024
1Epilepsy (Aura)
03/2024
1Catatonia
03/2024
1Confusion (Bewilderment)
01/2024
1Delirium
01/2024
1Sleep Initiation and Maintenance Disorders (Insomnia)
12/2023
1Intracranial Aneurysm (Cerebral Aneurysm)
01/2023
1Necrosis
12/2022

Drug/Important Bio-Agent (IBA)

30LithiumIBA
02/2024 - 03/2000
27Mitochondrial DNA (mtDNA)IBA
10/2023 - 12/2003
14DNA (Deoxyribonucleic Acid)IBA
02/2015 - 01/2005
13Biomarkers (Surrogate Marker)IBA
10/2023 - 10/2004
9CalciumIBA
01/2021 - 06/2003
7Messenger RNA (mRNA)IBA
02/2010 - 02/2003
6Antipsychotic Agents (Antipsychotics)IBA
03/2024 - 12/2003
6Hemoglobins (Hemoglobin)IBA
10/2004 - 04/2002
5Lurasidone HydrochlorideFDA Link
01/2023 - 12/2020
5Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2007
5Antidepressive Agents (Antidepressants)IBA
01/2020 - 10/2005
5Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2013 - 09/2004
5SarinIBA
01/2007 - 11/2002
4Serotonin (5 Hydroxytryptamine)IBA
09/2019 - 07/2010
3Cholinergic Agents (Cholinergics)IBA
07/2023 - 11/2020
3EnzymesIBA
07/2023 - 12/2019
3Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
12/2020 - 07/2013
3NucleotidesIBA
05/2015 - 12/2004
3Valproic Acid (Depakote)FDA LinkGeneric
11/2013 - 01/2009
35-HT2C Serotonin ReceptorIBA
04/2008 - 08/2003
2ChromatinIBA
03/2024 - 02/2015
2MicroRNAs (MicroRNA)IBA
10/2023 - 01/2018
2Protons (Proton)IBA
01/2023 - 01/2021
2Glutamic Acid (Glutamate)FDA Link
01/2023 - 01/2021
2Poly I-CIBA
01/2023 - 01/2014
2Interleukin-6 (Interleukin 6)IBA
12/2022 - 01/2022
2CytokinesIBA
12/2022 - 01/2018
2Dopamine (Intropin)FDA LinkGeneric
01/2021 - 09/2019
2nervonic acidIBA
01/2021 - 01/2018
2DNA Polymerase gammaIBA
08/2017 - 11/2010
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2015 - 02/2005
2hydrogen sulfite (bisulfite)IBA
01/2015 - 11/2013
2Transcription Factors (Transcription Factor)IBA
01/2013 - 06/2005
2Serotonin ReceptorsIBA
02/2010 - 07/2009
2Therapeutic UsesIBA
01/2009 - 08/2007
2glucose-regulated proteinsIBA
01/2009 - 01/2007
2TungstenIBA
06/2008 - 02/2003
2Electron Transport Complex I (NADH-CoQ Reductase)IBA
04/2006 - 10/2004
2Cholinesterases (Cholinesterase)IBA
06/2005 - 11/2002
2Phosphorus (Red Phosphorus)IBA
04/2005 - 02/2004
1MethyltransferasesIBA
03/2024
1Histone DemethylasesIBA
03/2024
1Lysine (L-Lysine)FDA Link
03/2024
1vafidemstatIBA
03/2024
1Histones (Histone)IBA
03/2024
1Lactic Acid (Lactate)FDA LinkGeneric
03/2024
1BenzodiazepinesIBA
12/2023
1lemborexantIBA
12/2023
15' Untranslated Regions (5' UTR)IBA
10/2023
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
07/2023
1Eicosapentaenoic AcidIBA
07/2023
1Fatty Acid DesaturasesIBA
07/2023
1Docosahexaenoic AcidsIBA
07/2023
1Transfer RNA (tRNA)IBA
05/2023
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2023
1Glutamine (L-Glutamine)FDA Link
01/2023
1Interleukin-8 (Interleukin 8)IBA
12/2022
1Interleukin-4 (Interleukin 4)IBA
12/2022
1ImmunosorbentsIBA
12/2022
1Interleukin-2 (IL2)IBA
12/2022
1InterleukinsIBA
12/2022

Therapy/Procedure

3Therapeutics
10/2022 - 01/2021
1Length of Stay
01/2024
1Critical Care (Surgical Intensive Care)
01/2024